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themhad upper respiratory infection due to congested and dusty environment. On
previous observation may of hajj pilgrims were given antibiotic for their URTIs.
Most of antibiotics prescribed to pilgrimswere based onprescribers judgments.The
study aims to determine the prevalence severity and the pattern of antibiotic
usage. METHODS: This cross sectional study was conducted from December 2007
to January 2008. Validated self administered questionnaire forms were distributed
to about 3,000 Malaysian Hajj Pilgrims in Makkah of Saudi Arabia. The severity of
URTIs was based on the patient’s perception and the number of symptoms.
RESULTS: Majority, 87.1% of 2194 pilgrims reported had URTIs, 12.4%, (41.6%) and
(46.0%) of pilgrims were categorised severe, moderate, and mild respectively. An-
tibiotics were prescribed to 58.8% pilgrims, the pattern of antibiotic used was as-
sociated with severity (p 0.001) and the number of symptoms(p 0.001)and 55.1%
of them had fever. Many of them(68.8%), take one course of antibiotic, while 28.5 %
and 8.0% received two and three causes. CONCLUSIONS: A high prevalence of
URTIs was found among Malaysian Hajj Pilgrims. Most of the pilgrims with mod-
erate to severe and had fever received antibiotics. About one third of them, how-
ever,were not get benefit fromfirst course of antibiotics. Proper antibiotic guideline
that supported by microbiological studies are proposed to justify the use of antibi-
otics for hajj pilgrims.
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OBJECTIVES: To evaluate the use of sedatives in critically ill adult patients with
endotracheal tube (ETT) and mechanical ventilator (MV) in a hospital in Taiwan.
METHODS:We conducted the study retrospectively by reviewing medical records.
All patients with ICD-9, 96.71, 96.72, 96.04, fromOct 2008 to Feb 2009were included.
Patients were excluded if they were pediatric patients, without complete records,
using MV after discharged, in regular wards, or using MV less than 24 hours. The
primary end point is the duration of mechanical ventilation. The secondary end
points were length of ICU stay, hospital stay and events of tracheostomy, reintu-
bation, self-extubation. Chi square and t-test were performed for dichotomous and
continuous variables respectively. SPSS (Version 13.0) was used. The data were log
transformed to address the non-normal distribution. RESULTS: We collected 50
events of insertion of endotracheal tube with mechanical ventilator (ETTMV) in
using sedatives group and 163 in not using group. The duration of mechanical
ventilation was not significantly difference between two groups. (p 0.582) The
using sedatives group had longer ICU (p 0.04) and hospital length of stay (p
0.001). There were much more patients were physically restricted in the using
sedatives group (84% vs. 56%). The usages of sedatives were 50% ofmidazolam and
54% of propofol. The mean treatment duration among patients receiving midazo-
lam was 4.6 days and 2.2 days among patients with propofol. This longer duration
of length of stayswere possibly related to the usage ofmidazolamand the prescrib-
ing habits of physicians. CONCLUSIONS: We found the physician preference by
using physical restriction as first line and sedatives as second line did not benefit
the critically ill patients.Wewill implement a sedation guideline to tailor the needs
of our facility for optimal the patient care.
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OBJECTIVES: To investigate the real-world diagnosis and treatment patterns of
iron deficiency anemia (IDA) in China. METHODS: Literature review, Key Opinion
Leaders survey, and patient case reviewwere conducted. The reviewwas based on
China Academic Journals Full-text Database (2006-2010). A total of 163 publications
were targeted by searching in terms of IDA diagnosis and treatment. A total of 44
senior physicians specialized in nephrology, hematology and obstetrics/gynecol-
ogy were selected from tertiary hospitals in Beijing, Shanghai, Guangzhou, She-
nyang and Chengdu, who were requested to complete a questionnaire in two
weeks. The structured questionnaire included IDA awareness, diagnosis, treat-
ment and related drivers and restrictions. Information on Lab tests and treatments
were collected from 91 patient cases. Descriptive analysis was performed. The
results of KOL survey and patient case review were consistent, indicating the va-
lidity of the results. RESULTS: IDA wasmost likely found in patients in nephrology
and obstetrics/gynecology, and in patients with chronic kidney disease on hemo-
dialysis. Seventy-five percent of nephrologists, 58% of hematologists, and 25% of
obstetricians/gynecologists reported the existence of hospital-wide guidelines for
IDA diagnosis and treatment, respectively. Lab tests and cut-off for IDA diagnosis
varied across different specialties and different physicians in the same specialty.
Intravenous (IV) ironwasmore effective and caused less side effects than oral iron.
IV iron sucrose increased hemoglobin level faster and greater than intramuscular
iron dextran. Nephrologists usually prescribed IV iron as the first line, while hema-
tologists and obstetricians/gynecologists preferred oral iron. Price was not the
most influential driver for using IV iron. Fifty-seven percent of KOLs, however,
reported the restrictions of IV iron use due to cost.CONCLUSIONS:Guideline-based
diagnosis and treatment for IDA needs to be strengthened in China. Real-world
prescription of IV iron for IDA varied across specialties andmay be restricted due to
cost despite its better effectiveness.
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OBJECTIVES: To develop national medicine brand substitution guidelines and as-
sessment of its adoptability among community pharmacist and general practitio-
ners in Malaysia.METHODS: A cross sectional postal survey was conducted with a
sample of 100 community pharmacists and 100 general practitioners selected sys-
tematically in the state of Penang, Malaysia. A pre validated questionnaire was
used for data collection. Frequencies and percentages were used to elaborate the
data. SPSS v. 16 was used for data analysis. RESULTS: From a total of 200 question-
naires mailed, the response rate was 16% (n16) for general practitioners and 36%
(n36) for community pharmacist. Majority of the respondents (n53, 85.4%) dis-
agreed that generic medicines lead to more side effect as compared to innovator
brands. However, 59.6% (n37) reported that Innovator brands are more effective
than genericmedicines. Moreover, (n33, 53.2%) agreed that genericsmedicine are
not bioequivalent to the innovator brands. Majority (n40, 64.5%) stated that ge-
nericmedicines should be available in samedosage formand strength as innovator
brand medicines. Almost all respondents (n52, 83.8%) demanded that dispensed
medicines should be labelled with the generic (INN) name of the medicine with or
without the brand name. While comparing with general physicians (n13, 81.3%),
community pharmacists (n33, 91.7%) were in high favor that a written national
generic brand substitution guideline is needed in Malaysia. In addition, all of the
respondents strongly agreed to the statement that thorough counselling should be
provided to the patients if their medicine is changed from innovator brand to
generic in order to avoid confusion. CONCLUSIONS: Majority of general practitio-
ners and community pharmacists in Penang agreed to the contents of the draft
national medicine brand substitution guideline. This is a good indicator that the
contents can actually be the foundation of an actual national medicine brand sub-
stitution guideline.
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OBJECTIVES: SMBG is one of the core components of diabetes therapy. It supports
a safe and effective drug therapy and provides additional feedback on howdiet and
lifestyle impact blood glucose levels. In 2011 a Chinese guideline on SMBG was
published. SMBG, in contrast to most diabetes drugs, is not reimbursed. This study
aims to assess the level of SMBG usage in patients on different diabetes therapies.
METHODS: 1st half year 2011 data (10,418 cases) from the CSD PDS Diabetes survey
were used for this explorative analysis. PDS Diabetes is a syndicated research with
a fixed representative panel of endocrinologists and cardiologists from 13 large
Chinese cities. Patient cases are documented in a standardized format. SMBGusage
was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 54%), basal
supported oral therapy (BOT 18%), conventional insulin therapy (CT 20%), intensive
insulin therapy (IIT 6%) and OTHERS (2% - not reported). RESULTS: Ninety-five
percent were patients with type 2 diabetes. A total of 5288 patients (50.8%) had a
meter for home-testing. Shares of testers by therapies (OAD / BOT / CT / IIT) were
34.7%, 60.1%, 53.4% and 48.4%. Average weekly test frequencies were 2.8, 3.3, 3.0
and 4.0 respectively. In the IIT group 1% tested at least 3 times a day. HbA1c levels
were by 0.2%, 0.5%, 0.4% and 1.2% lower in SMBG users. CONCLUSIONS:High share
of patients don’t have a meter to perform SMBG at home. For testers with BOT, CT
and IIT test-frequencies remained clearly below the Chinese guideline recom-
mending 10, 10 and 21 test per week respectively. For IIT (SMBG is needed to
support insulin dose adjustments) only 1% tested at the guideline-recommende
frequency. In IIT patients differences in HbA1 were largest between testers and
non-testers. Further research is needed to clarify if e. g. education or reimburse-
ment could potentially resolve these shortfalls.
PHP113
UTILIZATION OF FPG, HBA1C AND SELF-MONITORING OF BLOOD GLUCOSE
(SMBG) IN COMMUNITY HEALTH CENTERS IN THE SHANGHAI AREA
Mast O1, Tan A2
1Roche, Mannheim, Germany, 2Cegedim Strategic Data, Shanghai, China
OBJECTIVES:Utilization of fasting plasma glucose (FPG), HbA1c and SMBG are con-
sidered core components of diabetes therapy. They support a safe and effective
drug therapy and they provide feedback on the quality of glycemic control. In
2011 a Chinese guideline on SMBG was published. SMBG, in contrast to most dia-
betes drugs, is not reimbursed in China. This study aims to assess the level of SMBG
usage with patients on different diabetes therapies in community health centers
(primary care). METHODS: In 2012 a survey was conducted in community health
centers in 6 districts of Shanghai. 935 random diabetes cases were documented in
a standardized format. Subsequent explorative analysis were performed. SMBG
usage was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 84%),
any therapy involving insulin (INSULIN 14%) and OTHERS (2%). RESULTS: 99%were
patients with type 2 diabetes. FPG levels were available for 86% and 89% in OAD/
INSULIN respectively, HbA1c levelswere available for 32.0% and 19.4% respectively.
For 124 patients (13.3%) SMBG usage was reported, for 111 of them actual test
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frequencies were available. Shares of testers by therapies (OAD/INSULIN) were
10.0% and 21.8%. Physicians recommended an average of 5.9 tests per week, pa-
tients performed 2.8 (47.5%). For OAD/INSULIN test-frequencies were 2.8 and 2.2.
Doctors rated the SMBG adherence as good or very good in 43% of cases.
CONCLUSIONS: In community centers the vast majority of patients have type 2
diabetes. FPG values were broadly documented, but the therapy quality marker
HbA1 is only available for the minority of patients. SMBG was more common with
insulin users, but clearly below guideline recommendations. It needs to be deter-
mined which measures could potentially improve the current practice in diabetes
care in order to strengthen the role of community health centers in managing the
diabetes epidemic in China.
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OBJECTIVES:With high costs of some oncology and biological therapies, manufac-
turers have introduced patient access schemes in Asian countries including Indo-
nesia,Malaysia, Philippines andChinawhere the out-of-pocket is themain funding
and access mechanism. These schemes have been welcomed by stakeholders in-
volved including patients, clinicians and governments. Our objectivewas to under-
stand why such programmes have not succeeded in India despite a large middle
class and almost complete out-of-pocket funding for pharmaceuticals, and to find
possible ways to overcome the hurdles presented. METHODS: The approach in-
volved desk research followed by primary research across stakeholders in India.
Twelve in-depth telephone interviews were conducted with stakeholders in the
public and private sectors, NGOs, leading physicians and manufacturers. The in-
formation collected was assessed and analysed. RESULTS:Majority of the respon-
dents (n10) quoted bureaucracy and the informal economy, and thus difficulties
with means-testing as the twomost important reasons for the schemes not taking
up. General ignorance about the potential of such schemes and cynicism surround-
ing them are a deterrent. Unethical medical practice, a great patient – provider
knowledge gap and a lack of streamlined infrastructure for scheme delivery are
thought to be important factors. Respondents confirmed that majority of the large
middle class lacks access to innovative medicines for many diseases. The Gleevec
patient access scheme was quoted by a few respondents as a rare example of such
a scheme being run. Partnering with the public sector and NGOs was thought to be
an alternative way out. There was mention of many local NGOs/charities which
fund targeted oncology therapies for those with limited resources. CONCLUSIONS:
India needs tailored, innovative ways of accessing high cost drugs for its local
context being different from those in other countries in the region. Public-private
partnerships involving large stakeholders such as theMinistry of Railways could be
an option.
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OBJECTIVES: Access to medications is one of the main goals of Iran National Drug
Policy (NDP). Being a function of multifactors such as distribution of pharmacies, if
the geographical access is observed, drug accessibility is gauranteed to some ex-
tent. The aim of this study is to compare the Geographical distribution of pharma-
cies versus population in two capital cities of Iran. METHODS: Two cities of Iran
with strategical and transitional importance with cultural and socioeconomical
differences (Khorramabad and Ahwaz) were selected. In the first step the popula-
tion of different regions was collected from state government databases. Further-
more all of the pharmacies’ locations in these two cities were detected through
their Food andDrug deputies. The percent of population and pharmacies located in
each region were calculated and compared together by differentiating relatad per-
cents inorder to find an overview of present status of distribution and access to
pharmacies. RESULTS: Ahwaz and Khorramabad, twowest-southern cities of Iran,
with a population of approximately 1,000,000 and 5200,000 are seperated to eight
and three regions respectively. Unlike Khorramabad, an even distribution of pop-
ulation was found in Ahwaz. The differences in percent of population versus phar-
macies in order from first to eighth region of Ahwaz were found as followed: 13.8,
3.9, -4, -8.3, 6.1, -2.6, -5.6 and -3.3. Those of the three regions of Khorramabad were
-18, 17 and 1. CONCLUSIONS: The results show the distribution of pharmacies in
both cities does not match that of population in most regions. However in one
region of Khorramabad and three regions of Ahwaz the distribution was accept-
able. This can be justified by the fact that physicians are mostly concentrated in
few regions that attract the pharmacists. It should be noted that the suitablity of
population and pharmcies’ distribution is one of the most important factors in
evaluating access to medicine.
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OBJECTIVES: Chronic disease has become a major problem affecting the health of
the Chinese population. In response to this situation, the New Rural Cooperative
Medical Scheme (NRCMS) has begun to provide health cover for outpatients with
chronic disease expenses, made possible by the increased risk pool of recent years.
We compared the differences between benefit packages for chronic disease outpa-
tients in 32 counties, in order to assess their population reach, equity and cost
implications and to formulate recommendations for policy makers. METHODS:
Information on the various benefit packages was located by searching the official
NRCMS websites in Chinese at the end of 2009. We developed a conceptual frame-
work based on the three main criteria: 1) population coverage; 2) service coverage;
and 3) costs with various subcriteris to compare benefit packages in 32 counties
across China. Chronic diseases were classified according to the ICD-10. RESULTS:
With the intention of avoiding “moral hazard” county NRCMS offices have devel-
oped complex processes to define benefit packages for chronic diseases. These
have resulted in substantial differences in benefit package equity and cost between
counties. In most counties chronic disease patients find it very difficult to become
beneficiaries. Forty-one chronic diseaseswere identified in the 32 counties, varying
between 4 and 28 per individual county. We also found large discrepancies in
co-payment rates, deductibles, ceilings, coverage of drugs and tests, accredited
hospitals and reimbursement frequency. CONCLUSIONS: Reimbursement proce-
dures are remarkably diverse in different counties. Population coverage, service
coverage and cost of benefit packages for chronic diseases vary substantially in the
32 counties studied. This reflects the new policy of decentralization of decision
making to the county-level resulting in a “postcode lottery” of patient benefits.
National regulation to redress these inefficiencies and inequities is urgently
needed.
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OBJECTIVES: To evaluate health insurance coverage rate among poor and disad-
vantaged citizens and study the cause and condition of not being involved in health
insurance. METHODS: The sampling size was estimated by using the number of
poor and needy in selected districts. By using multistage–sampling method, con-
centration of poor and poverty group among the total person of selected districts
were calculated. There are sampling size at 5% sampling error (d5%), confidence
interval (CI95%) and the influence of non-sampling error estimated. RESULTS: In
the first years of health insurance in Mongolia, there was coverage achieved at
96-97%, but later it decreased because of diversity of employment‘s structure, in-
creasing unemployment rate, and most influential factor as PHC was excluded
from social health insurance. The result shows, HI coverage was 95.3% in 1998, but
this rate was decreased till 84.4% in 2008. 95-97% of people who were involved in
the survey, have lower income than living standard. According to the pattern of
age, majority includes 26-35 aged economic hummers and as of gender, there were
44.79 % male and 55.21% female. To survey whether all people who were involved
in the survey, got covered by health insurance last 3 years, there were 47.14% of
them involved in health insurance. As forms of paying insurance fee, 17.3% paid
insurance fee by voluntary, 49.17% paid by government and 33.7% paid by mixed
forms. To survey on the health insurance coverage during the survey, 42.4% were
involved. As forms of paying insurance fee, 27.61% paid by voluntary, 41.1% paid by
mixed. CONCLUSIONS: The health insurance cannot protect poor and disadvan-
taged citizens from financial and other risks. People cannot be provided by equal
and sufficient health services because of health insurance non-involvement,
breach of citizenship identification paper and no registration of citizenship. The
main reason of health insurance non-involvement depends on economic disad-
vantage and lack of information.
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OBJECTIVES: The implementation of the New Rural Cooperative Medical Scheme
(NRCMS) has been spreading fast since a county pilot trial began in September 2003.
The purpose of this survey was to guide policy makers of Huxian county and ulti-
mately improve the current national NRCMS policy. METHODS: Cross-sectional
survey of the attitudes of farmers towards the NRCMS conducted in 2005. A total of
1978 farmers living in 50 villages in Huxian Shaanxi Province were surveyed using
a door-to-door questionnaire. The survey asked farmers questions regarding their
awareness of the NRCMS and their opinions of the scheme, including methods of
reimbursement and raising funds and concerns regarding the scheme’s
sustainability.RESULTS:Most farmers hold a positive attitude towards theNRCMS.
There are issues, however, in regard to the farmers’ trust in the scheme and pre-
ferred payment methods. Farmers place more trust in village doctors rather than
village cadres for fund collection.More than two thirds of farmers visit county-level
hospitals directly when they require inpatient treatment. Not all hospitals and
doctors fully comply with the NRCMS rules, and supplier-induced demand is still
widespread. More than half the farmers stated that they worry that the NRCMS is
unable to be sustained. Importantly the survey showed a high enrolment rate of
92% (95% CI, 91; 93) in a voluntary insurance scheme. CONCLUSIONS: Despite a
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